Amundi Has $30.43 Million Stake in Molina Healthcare, Inc $MOH

Key Points

• Amundi has reduced its stake in Molina Healthcare by 25.9%, now holding 86,138 shares valued at approximately $30.4 million as of their latest filing.
• Multiple hedge funds have changed their positions in Molina, with Rothschild Investment LLC increasing its stake by 126.3% during the same period.
• Despite recent sell-offs, analysts show mixed ratings with three giving a Buy rating and ten a Hold rating, and a consensus price target of $225.18.

Amundi decreased its position in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 25.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 86,138 shares of the company's stock after selling 30,046 shares during the quarter. Amundi owned about 0.16% of Molina Healthcare worth $30,427,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of MOH. Price T Rowe Associates Inc. MD lifted its holdings in shares of Molina Healthcare by 46.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company's stock valued at $1,264,214,000 after buying an additional 1,216,903 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Molina Healthcare by 74,593.7% during the first quarter. GAMMA Investing LLC now owns 667,015 shares of the company's stock valued at $219,708,000 after purchasing an additional 666,122 shares during the last quarter. Voloridge Investment Management LLC lifted its holdings in shares of Molina Healthcare by 1,641.3% during the fourth quarter. Voloridge Investment Management LLC now owns 409,807 shares of the company's stock valued at $119,274,000 after purchasing an additional 386,273 shares during the last quarter. Two Sigma Investments LP purchased a new stake in shares of Molina Healthcare during the fourth quarter valued at $44,099,000. Finally, Nuveen LLC purchased a new stake in shares of Molina Healthcare during the first quarter valued at $46,441,000. Institutional investors and hedge funds own 98.50% of the company's stock.

Molina Healthcare Stock Down 2.0%

MOH stock traded down $3.69 during mid-day trading on Friday, hitting $184.75. The stock had a trading volume of 329,581 shares, compared to its average volume of 1,025,461. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.77. Molina Healthcare, Inc has a 1-year low of $151.95 and a 1-year high of $365.23. The company has a fifty day moving average of $180.61 and a 200 day moving average of $267.06. The stock has a market capitalization of $10.01 billion, a price-to-earnings ratio of 9.11 and a beta of 0.54.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share for the quarter, missing the consensus estimate of $5.50 by ($0.02). Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The firm had revenue of $11.43 billion during the quarter, compared to analyst estimates of $10.94 billion. During the same period in the previous year, the company earned $5.86 earnings per share. The business's revenue for the quarter was up 15.7% on a year-over-year basis. On average, equities analysts expect that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.

Insider Activity

In other news, COO James Woys bought 10,000 shares of the company's stock in a transaction on Monday, August 4th. The shares were bought at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the transaction, the chief operating officer directly owned 74,331 shares in the company, valued at approximately $11,591,176.14. This trade represents a 15.54% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Ronna Romney sold 700 shares of the company's stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the transaction, the director directly owned 17,131 shares in the company, valued at approximately $2,633,719.94. The trade was a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Mizuho reduced their target price on Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating for the company in a report on Friday, July 11th. Robert W. Baird reduced their target price on Molina Healthcare from $373.00 to $179.00 and set a "neutral" rating for the company in a report on Friday, July 25th. UBS Group reduced their target price on Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Barclays reduced their target price on Molina Healthcare from $186.00 to $185.00 and set an "equal weight" rating for the company in a report on Thursday, September 4th. Finally, Sanford C. Bernstein reduced their price objective on Molina Healthcare from $284.00 to $220.00 and set an "outperform" rating for the company in a research note on Friday, September 5th. Three research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. Based on data from MarketBeat.com, Molina Healthcare currently has an average rating of "Hold" and an average price target of $225.18.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.